We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.00 | 0.92% | 1,651.00 | 1,650.50 | 1,651.50 | 1,655.00 | 1,635.00 | 1,642.00 | 696,637 | 09:48:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
TIDMGSK
RNS Number : 9373B
GlaxoSmithKline PLC
15 January 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Ms E Walmsley === ====================== ================================= b) Position/status Chief Executive Officer === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3440 473.274 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ======================================================== a) Name Mr R G Connor === ====================== ================================ b) Position/status President, Global Manufacturing & Supply === ====================== ================================ c) Initial notification/ Initial notification amendment === ====================== ================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================== a) Name GlaxoSmithKline plc === ====================== ================================ b) LEI 5493000HZTVUYLO1D793 === ====================== ================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================ b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== ================================ c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3440 82.400 ------------ ---------- === ====================== ================================ d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================ e) Date of the 2018-01-11 transaction === ====================== ================================ f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr L Debruyne === ====================== ================================= b) Position/status President, Global Vaccines === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3440 851.563 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr S Dingemans === ====================== ================================= b) Position/status Chief Financial Officer === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3440 919.518 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated
with them ('PCA') === ========================================================= a) Name Mr D S Redfern === ====================== ================================= b) Position/status Chief Strategy Officer === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3440 1552.174 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Ms C Thomas === ====================== ================================= b) Position/status SVP, HR === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3440 599.748 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr P C Thomson === ====================== ================================= b) Position/status President, Global Affairs === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3440 728.198 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Dr P J T Vallance === ====================== ================================= b) Position/status President, R&D === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3440 2918.217 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mrs K Thomson === ====================== =================================
b) Position/status PCA of Mr P C Thomson (President, Global Affairs) === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3440 137.540 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== =================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDELFFVFFXBBF
(END) Dow Jones Newswires
January 15, 2018 12:34 ET (17:34 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions